세계의 심내 초음파 검사 시장 (~2029년)

■ 영문 제목 : Intracardiac Echocardiography Market / ICE Market Size, Share & Trends by Product (Ultrasound (2D, 3D/4D, Doppler), Catheter, Console, Software), Application (Valve Defects, Electrophysiology, Monitoring), End user (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029
	■ 상품 코드 : AST 9119 ■ 조사/발행회사 : MarketsandMarkets ■ 발행일 : 2024년 8월 ■ 페이지수 : 300 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문 후 1영업일) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD4,950 ⇒환산￦6,930,000	견적의뢰/주문/질문
Corporate License (동일기업내 공유가능)	USD8,150 ⇒환산￦11,410,000	견적의뢰/주문/질문

※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 심장강내 초음파(ICE) 시장은 2024년 3억 3,300만 달러에서 2029년 5억 4,500만 달러로 성장할 전망이며, 예측 기간(2024~2029) 연평균성장률(CAGR)은 10.3%로 제시된다. 성장 배경으로는 고령화, 진단기술의 지속적 발전, 고급 영상장비 도입 확대, 심장 구조와 혈류를 실시간 고해상도로 확인할 수 있는 임상적 가치가 꼽힌다. 제품별로는 ‘소프트웨어가 내장된 ICE 초음파 시스템(2D, 3D/4D, 도플러)’이 2024~2029년 기간 동안 가장 큰 비중을 차지할 것으로 전망되며, 트랜스듀서·카테터 설계 발전과 타 영상기술과의 통합(시각화·내비게이션 강화), 최소침습 시술 선호, 소프트웨어 고도화, 관상동맥질환 증가 등이 수요 확대 요인으로 제시된다. 적용 분야별로는 2023년 전기생리학(Electrophysiology)이 최대 비중을 차지했는데, 실시간 시각화로 시술 안전성과 정확도를 높이고 장기간 모니터링을 통해 조기 진단에 기여하는 점이 성장 동력으로 설명된다. 최종 사용자 기준으로는 2023년 ‘병원 및 수술센터(진단)’ 부문이 가장 큰 비중을 차지했으며, 진단기술 발전과 고품질 진단 서비스 수요 증가, 규제 환경 개선, 최신 진단 도구 도입 확산이 배경으로 언급된다. 지역별로는 아시아태평양(APAC)이 2024~2029년에 두드러진 성장세가 예상되며, 초음파 기술 혁신, 정부의 의료 인프라·첨단 의료기술 투자, 심혈관질환 증가로 인한 고급 진단·영상 수요 확대가 주요 요인으로 제시된다. 주요 기업으로는 Johnson & Johnson MedTech, Medtronic, Abbott, Siemens Healthineers, Philips(및 GE Healthcare 등)가 언급되며, 보고서는 제품·적용처·최종사용자·지역별 세분 시장, 성장 요인(심장질환 증가, 타 영상기술 및 AI와의 결합), 제약(숙련 인력 불균형, 합병증 위험), 기회(구조적 심질환 중재 영역에서 임상 적용 확대), 과제(비용 장벽), R&D 및 신제품 동향, 경쟁 구도와 시장 진입/투자 판단에 필요한 인사이트를 제공한다고 정리한다.

■ 보고서 개요

Intracardiac Echocardiography Market / ICE Market Size, Share & Trends by Product (Ultrasound (2D, 3D/4D, Doppler), Catheter, Console, Software), Application (Valve Defects, Electrophysiology, Monitoring), End user (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029

The global intracardiac echocardiography (ICE) market is projected to reach USD 545 million by 2029 from USD 333 million in 2024, growing at a CAGR of 10.3% during the forecast period. The projected market growth for intracardiac echocardiography (ICE) is supported by the convergence of benefits. The projected expansion of the intracardiac echocardiography (ICE) market is driven by demographic trends favoring an aging population, continuous advancements in diagnostic technologies, increased adoption of advanced imaging tools, and the capability to deliver real-time, high-resolution imaging of cardiac structures and blood flow. These factors synergistically contribute to the growth prospects of the ICE market in the forecasted period.

“ ICE Ultrasound Systems with Inbuild Software Applications segment to register largest market share in 2023-2029.”

Based on the product, the intracardiac echocardiography (ICE) market is segmented into ICE Ultrasound Systems with Inbuild Software Applications (2D ultrasound systems, 3D/4D ultrasound systems, doppler ultrasound systems), ICE Catheters (Dopper ICE catheters, phased – array ICE catheters, fixed – array ICE catheters, mechanical rotational ICE catheters) , ICE Consoles (cart/ trolley-based consoles, hand-held/ portable consoles), guiding catheters and sheaths, disposable accessories, and softwares are used in intracardiac echocardiography (ICE) taken into account while estimating the entire market. The ICE Ultrasound Systems segment registered the largest market share for the forecasted year of 2024-2029. Developments in ultrasound transducer technology and catheter designs, as well as its integration with other imaging tools to give comprehensive visualisation and navigation, are responsible for the emergence of intracardiac echocardiography ultrasound systems. Consumer demand for minimally invasive procedures, improved software applications, and an increase in the rate of coronary diseases are all contributing to the expansion and widespread use of ICE ultrasound devices.

“Electrophysiolgy segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by application.”

Based on the application, the intracardiac echocardiography (ICE) market is segmented into electrophysiology, structural heart defects (mitral valve repair/ replacement, aortic valve replacement and other heart defects), cardiac monitoring, left atrial appendage closure, and other applications. In 2023, the electrophysiolgy segment accounted the largest share of global intracardiac echocardiography (ICE) market. Real-time visualization capabilities, improved safety and accuracy in procedures, and the ability to monitor cardiac health over extended periods for early disease detection are pivotal drivers propelling growth in the electrophysiology in intracardia echocardiography market.

“hospitals & surgical centers: diagnostic segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by End-user.”

Based on the end-user, the intracardiac echocardiography (ICE) market is segmented into Hospital-based cathlabs/ hybrid or interventional, hospitals & surgical centers: diagnostic, Ambulatory surgical centers (ASCs) and independent diagnostic centers and Other end users. In 2023, the hospitals & surgical centers: diagnostic segment had the largest share of the global intracardiac echocardiography (ICE) market. The growth within hospital and surgical centers:diagnostic segment is propelled by continuous advancements in diagnostic technology, escalating consumer demand for superior diagnostic services, and facilitated expansion of diagnostic capabilities due to favorable regulatory environments and increased adoption of modern diagnostic tools.

“Asia Pacific to register significant growth rate in the market during the forecast period.”

For the forecasting period 2024-2029, The Asia-Pacific (APAC) region is anticipated to experience substantial growth throughout the forecast period. Asia Pacific comprises Japan, India, China, South Korea, Australia, and RoAPAC. The Asia-Pacific (APAC) region has experienced a notable acceleration in the market growth rate for intracardiac echocardiography (ICE). Several factors have contributed to the growth of the intracardiac echocardiography (ICE) market in the APAC region. Continuous innovations in ultrasound technology are driving this expansion. Additionally, governments in the Asia Pacific are making significant investments in healthcare infrastructure and advanced medical technologies. The rising incidence of cardiovascular diseases in the region further increases the demand for advanced diagnostic and imaging technologies like ICE, aiming to enhance patient care and outcomes.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%

By Designation: C-level– 27%, Director-level–18%, and Others–55%

By Region: North America–50%, Europe-20%, Asia Pacific–15%, Latin America–10%, and the Middle East & Africa–5%

Prominent players in this market are Johnson & Johson Medtech (US), Medtronic (Ireland), Abbott Laboratories (US), Siemens Healthineers (Germany), Philips healthcare (Netherland) among others.

Research Coverage

The report studies the intracardiac echocardiography (ICE) market based on products, application, end user, and region.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.

The report studies micro markets with respect to their growth trends, prospects, and contributions to the global intracardiac echocardiography (ICE) market.

The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the intracardiac echocardiography (ICE) market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

Analysis of key drivers (increasing cardiac issues in overall population, collaboration of other imaging techniques and AI with intracardiac echocardiography technology), restraints (The availability of trained personnel is inconsistent. Additionally, ICE procedures involve significant risks of complications), opportunities (scope of clinical applications for intracardiac echocardiography (ICE) in structural heart disease interventions is expanding), and challenges (incur cost barrier) influencing the growth of the intracardiac echocardiography (ICE) market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the intracardiac echocardiography (ICE) market.

Market Development: Comprehensive information about lucrative markets – the report analyses the intracardiac echocardiography (ICE) market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the intracardiac echocardiography (ICE) market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Siemens Healthineers (Germany), among others.

■ 보고서 목차

1. Introduction 2. Research Methodology 3. Executive Summary 4. Premium Insights 5. Market Overview 5.1 Introduction 5.2 Market Dynamics Drivers Emergence of predictive analytics in intracardiac echocardiography (ICE) technology Expansion of clinical use cases for ICE Ongoing integration of ICE with other imaging modalities Rising prevalence of cardiac disorders Restraints Premium pricing of ICE products Shortage of skilled healthcare professionals Opportunities Expanding clinical applications of ICE in structural heart disease interventions Advancements in 3D and real-time 3D (4D) imaging technologies Challenges Technical limitations Increasing pricing pressure on market participants 5.3 Porter’s Five Forces Analysis Threat of New Entrants Threat of Substitutes Bargaining Power of Suppliers Bargaining Power of Buyers Intensity of Competitive Rivalry 5.4 Regulatory Analysis Regulatory Bodies, Government Agencies, and Other Organizations Key Regulatory Guidelines North America Europe Asia Pacific 5.5 Reimbursement Scenario 5.6 Ecosystem Analysis 5.7 Investment and Funding Scenario 5.8 Technology Analysis Key Technologies Phased-array ICE Rotational ICE Doppler imaging 3D ICE technology Complementary Technologies Intravascular ultrasound (IVUS) Value-added software (AI and IoT) Clinical decision support systems Electrophysiology (EP) mapping systems Adjacent Technologies Event monitors Holter monitors 5.9 Value Chain Analysis Research and Development Procurement and Product Development Marketing, Sales and Distribution, and Post-sales Services 5.10 Supply Chain Analysis Prominent Companies Small and Medium-sized Enterprises End Users 5.11 Pricing Analysis Average Selling Price Trends of ICE Ultrasound Systems and Consoles, by Type (2022–2024) Average Selling Price Trends of ICE Products, by Type (2022–2024) Average Selling Price Trends of ICE Ultrasound Systems, by Key Player (2022–2024) Average Selling Price Trends of ICE Equipment, by Key Player (2022–2024) Indicative Pricing of ICE Ultrasound Systems, by Key Player (2022–2024) Average Selling Price Trends of ICE Products, by Region (2022–2024) Indicative Pricing of ICE Products, by Region (2022–2024) 5.12 Patent Analysis 5.13 Trade Analysis Import Data for ICE Devices (HS Code 901819), 2019–2023 Export Data for ICE Devices (HS Code 901819), 2019–2023 5.14 Key Conferences and Events (2025–2026) 5.15 Trends and Disruptions Impacting Customers’ Businesses 5.16 Key Stakeholders and Buying Criteria Key Stakeholders in the Buying Process Buying Criteria 5.17 Adjacent Market Analysis 5.18 Unmet Needs and Key Pain Points 5.19 Impact of Artificial Intelligence on the ICE Market 6. Intracardiac Echocardiography (ICE) Market, by Product 6.1 Introduction 6.2 ICE Ultrasound Systems with Inbuilt Software 2D Ultrasound Systems Increasing integration of modern ICE systems with other diagnostic platforms 3D/4D Ultrasound Systems Rising global incidence of cardiovascular diseases Doppler Ultrasound Systems High-resolution imaging and advanced Doppler techniques enhancing ICE capabilities 6.3 ICE Catheters Doppler ICE Catheters Growing preference for minimally invasive cardiac procedures Phased-array ICE Catheters High cost and limited applications constraining growth Fixed-array ICE Catheters Rising demand for advanced cardiac imaging solutions Mechanical Rotational ICE Catheters Innovations in catheter technology supporting adoption 6.4 ICE Consoles Cart/Trolley-based Consoles Increasing geriatric population driving demand Handheld/Portable Consoles Growing adoption of portable systems in healthcare facilities 6.5 Guiding Catheters and Sheaths Increasing integration with portable ICE consoles 6.6 Disposable Accessories Cost of disposable accessories influencing market growth 6.7 Software Rising adoption of predictive analytics for real-time imaging 7. Intracardiac Echocardiography (ICE) Market, by Application 7.1 Introduction 7.2 Structural Heart Defects Mitral Valve Repair/Replacement Aortic Valve Replacement Other Structural Heart Defects 7.3 Electrophysiology Increasing integration of ICE with mapping systems 7.4 Left Atrial Appendage Closure Reduced radiation exposure supporting adoption 7.5 Cardiac Monitoring Improved clinical decision-making and patient outcomes 7.6 Other Applications 8. Intracardiac Echocardiography (ICE) Market, by End User 8.1 Introduction 8.2 Hospitals and Surgical Centers Ability to manage high installation and maintenance costs 8.3 Ambulatory Surgical Centers Cost-effectiveness and operational convenience 8.4 Hospital-based Cath Labs and Hybrid/Interventional Centers Increasing use of ICE in minimally invasive procedures 8.5 Independent Diagnostic Centers Specialized expertise and access to advanced ICE technologies 8.6 Other End Users 9. Intracardiac Echocardiography (ICE) Market, by Region 9.1 Introduction 9.2 North America United States Canada 9.3 Europe Germany United Kingdom France Italy Spain Rest of Europe 9.4 Asia Pacific Japan China India Australia South Korea Rest of Asia Pacific 9.5 Latin America Brazil Mexico Rest of Latin America 9.6 Middle East and Africa GCC Countries Rest of Middle East and Africa 10. Competitive Landscape 10.1 Introduction 10.2 Key Player Strategies and Right-to-Win Framework 10.3 Revenue Analysis (2019–2023) 10.4 Market Share Analysis (2023) 10.5 Company Evaluation Matrix – Key Players 10.6 Company Evaluation Matrix – Startups and SMEs 10.7 Company Valuation and Financial Metrics 10.8 Product and Brand Comparison 10.9 Competitive Scenario Product Launches and Approvals Strategic Deals 11. Company Profiles 11.1 Key Players Medtronic plc Abbott Siemens Healthineers AG GE Healthcare Boston Scientific Corporation Philips Healthcare Johnson & Johnson MedTech Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Edwards Lifesciences Corporation Canon Medical Systems Corporation Fujifilm Holdings Corporation Guerbet Terumo Corporation LivaNova Infraredx, Inc. Stereotaxis, Inc. B. Braun SE Esaote S.p.A. 11.2 Other Players Chison Medical Technologies Shifamed, LLC Conavi Medical Inc. Xuzhou Kaixin Electronic Instrument Co., Ltd. BK Medical BenQ Medical Technology Echonous Inc. Volta Medical Trivitron Healthcare EchoPixel CathVision PIE Medical Imaging B.V.

※본 조사보고서 [세계의 심내 초음파 검사 시장 (~2029년)] (코드 : AST 9119) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 심내 초음파 검사 시장 (~2029년)] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!